FDA’s Sentinel System is engaged in numerous activities to protect and promote public health during the COVID-19 pandemic, ranging from monitoring the use of drugs, describing the course of illness among hospitalized patients, and evaluating the treatment impact of therapies actively being used under real-world conditions. Descriptions of efforts led by the Center for Drug Evaluation and Research are shown below. Please visit the links to learn more about each area of activity and also visit:
FDA Sentinel System's Coronavirus (COVID-19) Activities
Sentinel Projects
05/14/2020
This ongoing methods development project by the FDA Office of Counterterrorism and Emerging Threats (OCET) to examine outcomes among hospitalized patients with influenza-like illness and...
04/20/2020
This study aims to sequentially monitor priority drugs for the care of patients hospitalized with COVID-19, including sedatives and drugs used to assist with mechanical ventilation,...
04/07/2020
The purpose of this project is to identify promising sources of electronic health records to strengthen the Sentinel System in areas of pediatric, cancer, pregnancy, birth outcomes, and...
